Orange County NC Website
Browse       Search
0 <br />Page 1 of 2 <br />Alane Koki <br />Volunteer Application <br />Orange County Advisory Boards and Commissions <br />Name: <br />Name Called: <br />Home Address: <br />Phone: (Day) <br />Phone: (Evening) <br />Fax: <br />Email: <br />Place of Employment: <br />Job Title: <br />Township of Residence: <br />Zone of Residence: <br />Sex: <br />Ethnic Background: <br />Dr. Alane Koki <br />215 Ashe St. <br />Hillsborough NC 27278 <br />484-335-0050 <br />800-506-4501 <br />Kokiat2005@yahoo.com <br />BioProdigy Inc. <br />Chief Executive Officer <br />Hillsborough <br />Hillsborough Town Limits <br />Female <br />Other <br />Date of Birth: 3/4/1963 <br />Boards/Commissions applied for: <br />Work Experience: <br />I am writing to apply for the Animal Wellness/ Health Expert position on the Anti- <br />Tethering Committee. I have 15+ years of direct experience designing and monitoring <br />experimental animal protocols (rodents, dogs, pigs, primates) with animal safety, <br />veterinarians, and toxicology. Thirteen years experience in clinical protocol development <br />working with Clinical Institutional Review Boards, the FDA, and patient advocacy groups <br />to ensure patient safety during clinical trials. <br />President and Chief Executive Officer of BioProdigy Inc. Thirteen years experience in full <br />life cycle development of both drug and diagnostic development and clinical research. <br />10+ years experience in directing R & D of new drugs across many therapeutic arenas. <br />Principle contributor to the development of Celebrex, Bextra, and many anti-inflammatory <br />and anti-cancer agents. Three years experience in directing the use of <br />pharmacogenomic solutions to accelerate drug development, and full life cycle <br />development of 5 CE marked novel clinical diagnostics. Scientific <br />consultant/panelist/speaker at Academic and Clinical Institutions, including the National <br />Institutes of Health (NIH), National Cancer Institute (NCI), Southwest Oncology Group <br />(SWOG), and Gynecologic Oncology Group (GOG) to design and evaluate results on <br />Phase I-IV clinical trials. Primary advisor to Strategy Board to priorize/focus internal R & <br />D pipeline, in/out-licensing strategy, and significant contributor to Corporate Intelligence. <br />Budget and coordinate 120+ pre-clinical studies, and 50+ clinical trials from conception to <br />completion. Establish/implement effective bridges to initiate and foster synergies <br />between Discovery, Development, Toxicology, Clinical, Marketing, legal, and Medical <br />Affairs. Inventor on more than a dozen patents, and author of 60+ publications. <br />